Exhibit 32.1

​

CERTIFICATION UNDER SECTION 906

​

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Acurx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge that:

​

The Quarterly Report for the period ended March 31, 2022 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

​

​

​

​

Date: May 10, 2022

By:

/s/ David P. Luci

​

​

David P. Luci

​

​

Chief Executive Officer

​

​

(Principal Executive Officer)

​